Published in Br J Cancer on July 01, 1998
The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J Clin Pathol (2002) 0.81
Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis. Int J Clin Exp Pathol (2014) 0.78
Progestins and the endometrium in patients receiving tamoxifen. Br J Cancer (1999) 0.75
Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet (1994) 4.38
Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol (1995) 2.30
Tamoxifen and endometrial lesions. Lancet (1993) 2.07
Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos (1991) 2.04
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer (1989) 1.78
Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res (1992) 1.78
The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet (1992) 1.63
Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Case report. Br J Obstet Gynaecol (1990) 1.54
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme. Eur J Cancer (1990) 1.47
Pathology of endometrium treated with tamoxifen. J Clin Pathol (1994) 1.27
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat (1994) 1.24
Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps. Ultrasound Obstet Gynecol (1994) 1.22
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol (1993) 1.17
Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynaecol Obstet (1991) 1.12
Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis (1992) 1.08
Hysteroscopic follow-up during tamoxifen treatment. Eur J Obstet Gynecol Reprod Biol (1990) 0.95
Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol (1993) 0.93
Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res (1996) 0.93
Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen. Carcinogenesis (1994) 0.88
32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen. Carcinogenesis (1995) 0.80
Tamoxifen therapy and carcinogenic risk. J Natl Cancer Inst (1995) 0.80
Endometrial changes in patients on tamoxifen. Lancet (1995) 0.80
A C. elegans mutant that lives twice as long as wild type. Nature (1993) 20.42
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest (1998) 6.76
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet (1998) 5.35
Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell (1985) 5.25
Overview of the main outcomes in breast-cancer prevention trials. Lancet (2003) 4.31
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
Identification of the sequence responsible for the nuclear accumulation of the influenza virus nucleoprotein in Xenopus oocytes. Cell (1985) 3.36
Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res (2000) 3.03
Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med (1993) 2.96
Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol (1996) 2.76
Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol Cell (2000) 2.76
Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography. Ultrasound Obstet Gynecol (2013) 2.73
A cladistic analysis of phenotype associations with haplotypes inferred from restriction endonuclease mapping. II. The analysis of natural populations. Genetics (1988) 2.68
The management of histologically unverified presumed cerebral gliomas with radiotherapy. Int J Radiat Oncol Biol Phys (1994) 2.65
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A (1991) 2.53
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet (2000) 2.50
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol (1993) 2.50
Diagnosing ectopic pregnancy and current concepts in the management of pregnancy of unknown location. Hum Reprod Update (2013) 2.47
Platinum-based chemotherapy in triple-negative breast cancer. Ann Oncol (2008) 2.46
Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst (1994) 2.45
Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol (2006) 2.40
Limitations of current definitions of miscarriage using mean gestational sac diameter and crown-rump length measurements: a multicenter observational study. Ultrasound Obstet Gynecol (2011) 2.31
Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. J Exp Med (1987) 2.28
Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet (1998) 2.27
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet (1999) 2.27
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review. Ultrasound Obstet Gynecol (2014) 2.23
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol (1998) 2.18
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation (2001) 2.03
Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J Biol Chem (2000) 1.98
Does the presence of a cesarean section scar influence the site of placental implantation and subsequent migration in future pregnancies: a prospective case-control study. Ultrasound Obstet Gynecol (2012) 1.98
Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells. Immunogenetics (1987) 1.97
Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J (1998) 1.97
The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem (1993) 1.94
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
Reconstitution of an endocytic fusion event in a cell-free system. Cell (1985) 1.92
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol (2003) 1.92
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol (2000) 1.89
Altering telomere structure allows telomerase to act in yeast lacking ATM kinases. Curr Biol (2001) 1.89
Kinetic studies of gene frequency. I. Use of a DNA copy of reticulocyte 9 S RNA to estimate globin gene dosage in mouse tissues. J Mol Biol (1974) 1.87
Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer. Br J Cancer (2004) 1.87
Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol (2008) 1.86
Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) group. Ultrasound Obstet Gynecol (2010) 1.86
Broken rotational symmetry in the pseudogap phase of a high-T(c) superconductor. Nature (2010) 1.82
Kinetic studies of gene frequency. II. Complexity of globin complementary DNA and its hybridization characteristics. J Mol Biol (1974) 1.78
Selection of axial growth sites in yeast requires Axl2p, a novel plasma membrane glycoprotein. Genes Dev (1996) 1.75
Mouse globin gene expression in erythroid and non-erythroid tissues. Cell (1976) 1.75
A high incidence of vertebral fracture in women with breast cancer. Br J Cancer (1999) 1.74
Symptomatic zinc deficiency in a breast-fed preterm infant. Arch Dis Child (1980) 1.74
Nationwide survey of human parasite in China. Southeast Asian J Trop Med Public Health (1994) 1.72
Translation of mouse globin messenger ribonucleic acid from which the poly(adenylic acid) sequence has been removed. Biochemistry (1974) 1.72
Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1. Infect Immun (2000) 1.71
Oestrogens, arterial status, and postmenopausal women. Lancet (1990) 1.70
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer (2004) 1.69
Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet (2001) 1.67
Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ (1992) 1.63
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol (1985) (1999) 1.61
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin. J Clin Oncol (2001) 1.61
The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant (2011) 1.60
Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J Biol Chem (1997) 1.58
Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood (2000) 1.58
Surgical experience and supervision may influence the quality of lower limb amputation. Ann R Coll Surg Engl (2002) 1.57
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet (1999) 1.57
Allele specific amplification by tetra-primer PCR. Nucleic Acids Res (1992) 1.56
Vaccine prophylaxis of abattoir-associated Q fever. Lancet (1984) 1.55
Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol (2006) 1.55
Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial. Digestion (1990) 1.54
The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant (2010) 1.54
Short-term results of femoropopliteal subintimal angioplasty. Br J Surg (2000) 1.54
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet (2000) 1.53
Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol (1998) 1.53
Schizosaccharomyces pombe map3+ encodes the putative M-factor receptor. Mol Cell Biol (1993) 1.53
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Ann Oncol (1999) 1.51
HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet (1993) 1.50
Ricin A chain utilises the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of yeast. FEBS Lett (1999) 1.49
There is no role for uterine curettage in the contemporary diagnostic workup of women with a pregnancy of unknown location. Hum Reprod (2006) 1.49
Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma. Clin Oncol (R Coll Radiol) (2000) 1.49
Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation (1997) 1.48
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am J Transplant (2015) 1.48
In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol (1991) 1.48
Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol. Br J Cancer (1998) 1.48
Biodegradable rapamycin-eluting nano-fiber membrane-covered metal stent placement to reduce fibroblast proliferation in experimental stricture in a canine model. Endoscopy (2013) 1.48
Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action. J Immunol (1986) 1.47
c-erbB-2 expression in benign and malignant breast disease. Br J Cancer (1988) 1.47
Impact of ovulation and implantation timing on first-trimester crown-rump length and gestational age. Ultrasound Obstet Gynecol (2012) 1.46
Cervical cytology screening in two Yorkshire areas: pattern of service. Public Health (1981) 1.45
Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests. Ultrasound Obstet Gynecol (2011) 1.44
British Dietetic Association evidence-based guidelines for the dietary management of Crohn's disease in adults. J Hum Nutr Diet (2013) 1.44
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter? Br J Cancer (2009) 1.44
Photodynamic therapy in the canine prostate using motexafin lutetium. Clin Cancer Res (2001) 1.43
The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43
Impact of the availability of sonography in the acute gynecology unit. Ultrasound Obstet Gynecol (2006) 1.43